Concepedia

Shengze Yu

SY

Statistics

Publications

6

Citations

136

H-Index

6

Active since

2016

Affiliations

KTH Royal Institute of Technology(Current)

Karolinska Institutet

Affibody (Sweden)

Sultan Qaboos University

Shengze Yu is an author at KTH Royal Institute of Technology specializing in molecular oncology, oncology, and life sciences.

Publications per year

2016–2022

6

Publications

6

In vivo depletion of serum IgG by an affibody molecule binding the neonatal Fc receptor

Johan Seijsing, Shengze Yu, Fredrik Y. Frejd et al. · Scientific Reports · 2018 · 47 citations · Full text

, , +17

The antitumor role of a newly discovered α-d-glucan from Holotrichia diomphalia Bates as a selective blocker of aldolase A

Jingmei Wang, Zezhi Li, Xin Yang et al. · Carbohydrate Polymers · 2020 · 24 citations

, , +10

Fusion of the mouse IgG1 Fc domain to the VHH fragment (ARP1) enhances protection in a mouse model of rotavirus

Gökçe Günaydın, Shengze Yu, Torbjörn Gräslund et al. · Scientific Reports · 2016 · 23 citations · Full text

, , +17

Stimulation of prolactin receptor induces STAT-5 phosphorylation and cellular invasion in glioblastoma multiforme

Amira Alkharusi, Shengze Yu, Natalia Landázuri et al. · Oncotarget · 2016 · 17 citations · Full text

, , +14

Preclinical Evaluation of a New Format of 68Ga- and 111In-Labeled Affibody Molecule ZIGF-1R:4551 for the Visualization of IGF-1R Expression in Malignant Tumors Using PET and SPECT

Yongsheng Liu, Shengze Yu, Tianqi Xu et al. · Pharmaceutics · 2022 · 15 citations · Full text

, , +17

1–5 of 6